Abstract
For chronic thromboembolic pulmonary hypertension (CTEPH), well-established and standardized pulmonary endarterectomy (PEA) is still the first-line therapy with the favorable early and late outcome, particularly, for the proximal lesions of CTEPH. Reperfusion lung injury and residual pulmonary hypertension (PH) remain problematic as the complications related to adverse outcome. However, with the recent advancement of PEA including the adequate patients’ selection, the perioperative management, and the technical refinement with accumulation of experiences, the early outcome has been improved with the significant hemodynamic improvement and the lower mortality rates of 5–10 % in general and of less than 5 % in experienced centers. The late outcome is also promising with the low rates of recurrence of CTEPH. On the other hand, an alternative procedure of balloon pulmonary angioplasty (BPA) has been emerging as a less-invasive treatment mainly for difficult patients with inaccessible distal CTEPH lesions and for patients with residual PH after PEA. In these situations, it has been more important to choose the most adequate procedure for each patient and to do, if necessary, the combination therapies of PEA and BPA associated with medical treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moser KM, Daily PO, Peterson K, Dembitsky W, Vapnek JM, Shure D, et al. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Immediate and long-term results in 42 patients. Ann Intern Med. 1987;107(4):560–5.
Daily PO, Johnston GG, Simmons CJ, Moser KM. Surgical management of chronic pulmonary embolism: surgical treatment and late results. J Thorac Cardiovasc Surg. 1980;79(4):523–31.
Daily PO, Dembitsky WP, Iversen S. Technique of pulmonary thrombo- endarterectomy for chronic pulmonary embolism. J Card Surg. 1989;4:10–24.
Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM, Moser KM, et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg. 1993;106(1):116–26.
Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–62.
Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Jamieson SW, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg. 2012;94(1):97–103.
Nakajima N, Kawazoe K, Ando M, Uemura S, Fujita T. An experience in the surgical treatment of chronic pulmonary embolism. Nihon Kyobu Geka Gakkai Zasshi. 1986;34(4):524–31.
Ando M, Takamoto S, Okita Y, Matsukawa R, Nakanishi N, Kyotani S, et al. Surgery for chronic pulmonary thromoboembolism accompanied by thrombophilia in eight patients. Ann Thorac Surg. 1998;66:1919–24.
Ando M, Okita Y, Tagusari O, Kitamura S, Nakanishi N, Kyotani S. Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients. J Card Surg. 1999;14:377–85.
Masuda M, Nakajima N. Our experience of surgical treatment for chronic pulmonary thromboembolism. Ann Thorac Cardiovasc Surg. 2001;7:261–5.
Committee for Scientific Affairs. Thoracic and cardiovascular surgery in Japan during 2013: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2015;63(12):670–701.
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–1830.
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.
Nakanishi N, Ando M, Ueda H, Ogino H, Saji T, Shiomi T, et al. Guideline for treatment of pulmonary hypertension (Japanese); 2012. p. 50–6.
Kim NH, Delcroix M, Jenkins DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2014;2(25 Suppl):D92–9.
Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation. 2014;130(6):508–18.
Jenkins D. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2015;24(136):263–71.
Thistlethwaite PA, Mo M, Madani MM, Blanchard D, Kapelanski DP, Jamieson SW, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg. 2002;124(6):1203–11.
Mayer E, Jenkins D, Lindner J, D’Armini A, Kloek J, Meyns B, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141(3):702–10.
Ogino H, Ando M, Matsuda H, Minatoya K, Sasaki H, Nakanishi N, et al. Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2006;82(2):630–6.
Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103(1):10–3.
Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):748–55.
Kataoka M, Inami T, Hayashida K, Fukuda K, Yoshino H, Satoh T, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):756–62.
Hartz RS, Byrne JG, Levitsky S, Park J, Rich S. Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg. 1996;62:1255–9.
Thistlethwaite PA, Kemp A, Du L, Madani MM, Jamieson SW. Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2006;131(2):307–13.
Galiè N, Kim NH. Pulmonary microvascular disease in chronic thrombo- embolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3(7):571–6.
Reesink HJ, Marcus JT, Tulevski II, Jamieson S, Kloek JJ, Vonk Noordegraaf A, et al. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg. 2007;133:58–64.
Menzel T, Kramm T, Wagner S, Mohr-Kahaly S, Mayer E, Meyer J, et al. Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy. Ann Thorac Surg. 2002;73:756–61.
Thistlethwaite PA, Jamieson SW. Tricuspid valvular disease in the patient with chronic pulmonary thromboembolic disease. Curr Opin Cardiol. 2003;18:111–6.
Kitamura T, Morota T, Takamoto S. Emergent pulmonary thromboendarterectomy with percutaneous cardiopulmonary support system for chronic thromboembolic pulmonary hypertension. Eur J Cardiothorac Surg. 2003;24(4):656–8.
Tscholl D, Langer F, Wendler O, Wilkens H, Georg T, Schäfers HJ. Pulmonary thromboendarterectomy--risk factors for early survival and hemodynamic improvement. Eur J Cardiothorac Surg. 2001;19(6):771–6.
Mo M, Kapelanski DP, Mitruka SN, Auger WR, Fedullo PF, Jamieson SW, et al. Reoperative pulmonary thrombo-endarterectomy. Ann Thorac Surg. 1999;68(5):1770–6.
Madani MM, Wittine LM, Auger WR, Fedullo PF, Kerr KM, Jamieson SW, et al. Chronic thromboembolic pulmonary hypertension in pediatric patients. J Thorac Cardiovasc Surg. 2011;141(3):624–30.
Thistlethwaite PA, Auger WR, Madani MM, Pradhan S, Kapelanski DP, Jamieson SW. Pulmonary thrombo- endarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. Ann Thorac Surg. 2001;72(1):13–7.
Jenkins DP, Madani M, Mayer E, Kerr K, Kim K, Klepetko W, et al. Surgical treatment of CTEPH. ERJ Express. 2012;8
Thistlethwaite PA, Madani MM, Kemp AD, Hartley M, Auger WR, Jamieson SW. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg. 2006;82:2139–45.
Berman M, Tsui S, Vuylsteke A, Snell A, Colah S, Latimer R, et al. Successful extracorporeal membrane oxygenation support after pulmonary thrombo-endarterectomy. Ann Thorac Surg. 2008;86(4):1261–7.
Macchiarini P, Kamiya H, Hagl C, Winterhalter M, Barbera J, Haverich A, et al. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: is deep hypothermia required? Eur J Cardiothorac Surg. 2006;30(2):237–41.
Vuylsteke A, Sharples L, Charman G, Kneeshaw J, Tsui S, Dunning J, et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet. 2011;378(9800):1379–87.
Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation. 2009;120:1248–54.
Nagaya N, Ando M, Ogino H, Sakamaki F, Kyotani S, Nakanishi N, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest. 2003;123(2):338–43.
Freed DH, Thomson BM, Berman M, Tsui SS, Dunning J, Sheares KK, et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg. 2011;141(2):383–7.
Takeuchi M, Imanaka H, Tachibana K, Ogino H, Ando M, Nishimura M. Recruitment maneuver and high positive end-expiratory pressure improve hypoxemia in patients after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism. Crit Care Med. 2005;33(9):2010–4.
Haydar A, Malhere T, Mauriat P, Journois D, Pouard P, Denis N, et al. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet. 1992;340(8834–8835):1545.
Imanaka H, Miyano H, Takeuchi M, Kumon K, Ando M. Effects of nitric oxide inhalation after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism. Chest. 2000;118(1):39–46.
Ogino H. Recent advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension including Japanese experiences. Gen Thorac Cardiovasc Surg. 2014;62(1):9–18.
Kunihara T, Gerdts J, Groesdonk H, Sata F, Langer F, Schäfers HJ, et al. Predictors of postoperative outcome after pulmonary endarterectomy from a 14-year experience with 279 patients. Eur J Cardiothorac Surg. 2011;40(1):154–61.
Ishida K, Masuda M, Nakajima N. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2012;144(2):321–6.
Mayer E, Dahm M, Hake U, Schmid FX, Pitton M, Kupferwasser I, et al. Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 1996;61(6):1788–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Ogino, H. (2017). Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension. In: Fukumoto, Y. (eds) Diagnosis and Treatment of Pulmonary Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-287-840-3_16
Download citation
DOI: https://doi.org/10.1007/978-981-287-840-3_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-287-839-7
Online ISBN: 978-981-287-840-3
eBook Packages: MedicineMedicine (R0)